Brain Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Cancer, including details on symptoms, benign and malignant tumors, gliomas, treatment.

Volume 2 (2005), Issue 4 (April)

1. Atypical teratoid/rhabdoid tumor case report: treatment with surgical excision, radiation therapy, and alternative medicines.
   J Neurooncol, 72(1): 85-8. [Abstract] [Full-text]
2. Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.
   J Neurooncol, 72(1): 77-84. [Abstract] [Full-text]
3. Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas.
   J Neurooncol, 72(1): 57-62. [Abstract] [Full-text]
4. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
   J Neurooncol, 72(1): 35-46. [Abstract] [Full-text]
5. DeltaNp73 antisense activates PUMA and induces apoptosis in neuroblastoma cells.
   J Neurooncol, 72(1): 29-34. [Abstract] [Full-text]
6. Analysis of chromosome 7 in adult and pediatric ependymomas using chromogenic in situ hybridization.
   J Neurooncol, 72(1): 25-8. [Abstract] [Full-text]
7. Antisense bcl-2 transfection up-regulates anti-apoptotic and anti-oxidant thioredoxin in neuroblastoma cells.
   J Neurooncol, 72(1): 17-23. [Abstract] [Full-text]
8. Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton.
   J Neurooncol, 72(1): 11-6. [Abstract] [Full-text]
9. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
   J Neurooncol, 72(1): 1-9. [Abstract] [Full-text]
10. An oncolytic HSV-1 mutant expressing ICP34.5 under control of a nestin promoter increases survival of animals even when symptomatic from a brain tumor.
    Cancer Res, 65(7): 2832-9. [Abstract] [Full-text]
11. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors.
    Cancer Res, 65(7): 2755-60. [Abstract] [Full-text]
12. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma.
    Cancer Res, 65(7): 2565-71. [Abstract] [Full-text]
13. Glioblastoma multiforme in pregnancy.
    J Matern Fetal Neonatal Med, 17(1): 81-3. [Abstract] [Full-text]
14. Mixed neuronal-glial tumor of the fourth ventricle and successful treatment of postoperative mutism with bromocriptine: case report.
    Surg Neurol, 63(4): 375-9. [Abstract] [Full-text]
15. Intracranial cavernous angioma: a practical review of clinical and biological aspects.
    Surg Neurol, 63(4): 319-28; discussion 328. [Abstract] [Full-text]
16. Diagnosis and surgical treatment of brainstem hemangioblastomas.
    Surg Neurol, 63(4): 307-15; discussion 315-6. [Abstract] [Full-text]
17. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up.
    Clin Endocrinol (Oxf), 62(4): 397-409. [Abstract] [Full-text]
18. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis.
    Genes Chromosomes Cancer, 43(2): 181-93. [Abstract] [Full-text]
19. Evolving role of myeloablative chemotherapy in the treatment of childhood brain tumours.
    Bone Marrow Transplant, 35: S31-4. [Abstract] [Full-text]
20. Widespread dispersion of adeno-associated virus serotype 1 and adeno-associated virus serotype 6 vectors in the rat central nervous system and in human glioblastoma multiforme xenografts.
    Hum Gene Ther, 16(3): 381-92. [Abstract] [Full-text]
21. Lessons learned from randomised clinical trials in adult low grade glioma.
    Lancet Oncol, 6(4): 240-4. [Abstract] [Full-text]
22. Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
    Histopathology, 46(4): 403-12. [Abstract] [Full-text]
23. Blockage of angiotensin II type I receptor decreases the synthesis of growth factors and induces apoptosis in C6 cultured cells and C6 rat glioma.
    Br J Cancer, 92(7): 1247-52. [Abstract] [Full-text]
24. Genetic alterations in brain tumors following 1,3-butadiene exposure in B6C3F1 mice.
    Toxicol Pathol, 33(3): 307-12. [Abstract] [Full-text]
25. Stereotactic radiosurgery: the patient's experience.
    Soc Sci Med, 60(11): 2561-73. [Abstract] [Full-text]
26. Clinically silent somatotropinomas may be biochemically active.
    J Clin Endocrinol Metab, 90(4): 2117-21. [Abstract] [Full-text]
27. Intracarotid delivery of oncolytic HSV vector G47Delta to metastatic breast cancer in the brain.
    Gene Ther, 12(8): 647-54. [Abstract] [Full-text]
28. Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors.
    J Clin Endocrinol Metab, 90(4): 2179-86. [Abstract] [Full-text]
29. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5.
    Eur J Endocrinol, 152(4): 645-54. [Abstract] [Full-text]
30. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
    Eur J Endocrinol, 152(4): 557-67. [Abstract] [Full-text]
31. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study.
    Int J Radiat Oncol Biol Phys, 61(5): 1503-9. [Abstract] [Full-text]
32. Initial clinical experience with frameless radiosurgery for patients with intracranial metastases.
    Int J Radiat Oncol Biol Phys, 61(5): 1467-72. [Abstract] [Full-text]
33. Hypofractionated conformal stereotactic radiotherapy alone or in combination with whole-brain radiotherapy in patients with cerebral metastases.
    Int J Radiat Oncol Biol Phys, 61(5): 1460-6. [Abstract] [Full-text]
34. A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma.
    Int J Radiat Oncol Biol Phys, 61(5): 1454-9. [Abstract] [Full-text]
35. Differential phosphodiesterase expression and cytosolic Ca2+ in human CNS tumour cells and in non-malignant and malignant cells of rat origin.
    J Neurochem, 93(2): 321-9. [Abstract] [Full-text]
36. Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue.
    J Neurochem, 93(2): 299-309. [Abstract] [Full-text]
37. Primary hypothyroidism in a child mimicking a pituitary macroadenoma.
    Horm Res, 63(2): 61-4. [Abstract] [Full-text]
38. Successful pregnancy and delivery after removal of gonadotrope adenoma secreting follicle-stimulating hormone in a 29-year-old amenorrheic woman.
    Gynecol Obstet Invest, 59(3): 138-43. [Abstract] [Full-text]
39. Enhanced antitumor activity of irofulven in combination with irinotecan in pediatric solid tumor xenograft models.
    Cancer Chemother Pharmacol, 55(5): 411-9. [Abstract] [Full-text]
40. Germinoma of the basal ganglia. An 8-year asymptomatic history after detection of abnormality on CT.
    Pediatr Neurosurg, 40(6): 306-11. [Abstract] [Full-text]
41. Synchronous optic and pineal pilocytic astrocytomas in a paediatric patient with neurofibromatosis type 1.
    Pediatr Neurosurg, 40(6): 301-5. [Abstract] [Full-text]
42. Preclinical and clinical evaluation of O-[11C]methyl-L-tyrosine for tumor imaging by positron emission tomography.
    Nucl Med Biol, 32(3): 253-62. [Abstract] [Full-text]
43. No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours.
    Acta Neurol Scand, 111(5): 317-22. [Abstract] [Full-text]
44. O-(2-[18F]fluorethyl)-L-tyrosine PET in the clinical evaluation of primary brain tumours.
    Eur J Nucl Med Mol Imaging, 32(4): 422-9. [Abstract] [Full-text]
45. Peripheral primitive neuroectodermal tumor of the cerebellopontine angle.
    Acta Otolaryngol, 125(4): 426-9. [Abstract] [Full-text]
46. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults.
    Clin Neurol Neurosurg, 107(3): 207-13. [Abstract] [Full-text]
47. Diffusion tensor imaging for preoperative evaluation of tumor grade in gliomas.
    Clin Neurol Neurosurg, 107(3): 174-80. [Abstract] [Full-text]
48. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response.
    Proc Natl Acad Sci U S A, 102(15): 5524-9. [Abstract] [Full-text]
49. Detection of experimentally induced brain tumors in rats using high resolution computed tomography.
    Neurol Res, 27(1): 57-9. [Abstract] [Full-text]
50. Congenital intracranial immature teratoma of the lateral ventricle: a case report and review of the literature.
    Neurol Res, 27(1): 53-6. [Abstract] [Full-text]
51. Diagnostic value of super-selective bilateral cavernous sinus sampling with hypothalamic stimulating hormone loading in patients with ACTH-producing pituitary adenoma.
    Neurol Res, 27(1): 11-5. [Abstract] [Full-text]
52. Testosterone replacement-induced hyperprolactinaemia: case report and review of the literature.
    Ann Clin Biochem, 42: 153-9. [Abstract] [Full-text]
53. Fos-related antigen 1 modulates malignant features of glioma cells.
    Mol Cancer Res, 3(4): 237-49. [Abstract] [Full-text]
54. Id2 mediates tumor initiation, proliferation, and angiogenesis in Rb mutant mice.
    Mol Cell Biol, 25(9): 3563-74. [Abstract] [Full-text]
55. Statistical validation of brain tumor shape approximation via spherical harmonics for image-guided neurosurgery.
    Acad Radiol, 12(4): 459-66. [Abstract] [Full-text]
56. Cost of temozolomide therapy and global care for recurrent malignant gliomas followed until death.
    Neuro-oncol, 7(2): 189-95. [Abstract] [Full-text]
57. Phase 2 study of T138067-sodium in patients with malignant glioma: Trial of the National Cancer Institute of Canada Clinical Trials Group.
    Neuro-oncol, 7(2): 183-8. [Abstract] [Full-text]
58. Oral sodium phenylbutyrate in patients with recurrent malignant gliomas: a dose escalation and pharmacologic study.
    Neuro-oncol, 7(2): 177-82. [Abstract] [Full-text]
59. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
    Neuro-oncol, 7(2): 164-76. [Abstract] [Full-text]
60. Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment.
    Neuro-oncol, 7(2): 154-63. [Abstract] [Full-text]
61. Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.
    Neuro-oncol, 7(2): 134-53. [Abstract] [Full-text]
62. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis.
    Neuro-oncol, 7(2): 122-33. [Abstract] [Full-text]
63. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
    Neuro-oncol, 7(2): 106-21. [Abstract] [Full-text]
64. Combination gene therapy for glioblastoma involving herpes simplex virus vector-mediated codelivery of mutant IkappaBalpha and HSV thymidine kinase.
    Cancer Gene Ther, 12(5): 487-96. [Abstract] [Full-text]
65. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas.
    Cancer Res, 65(8): 3307-18. [Abstract] [Full-text]
66. Surgical and radiosurgical management of brain metastases.
    Surg Clin North Am, 85(2): 329-45. [Abstract] [Full-text]
67. Atypical teratoid/rhabdoid tumor of the brain: cytopathologic characteristics and differential diagnosis.
    Cancer, 105(2): 65-70. [Abstract] [Full-text]
68. Comparison of gadobenate dimeglumine (Gd-BOPTA) with gadopentetate dimeglumine (Gd-DTPA) for enhanced MR imaging of brain and spine tumours in children.
    Pediatr Radiol, 35(5): 501-10. [Abstract] [Full-text]
69. Pineal gland lesions: a cytopathologic study of 20 specimens.
    Cancer, 105(2): 80-6. [Abstract] [Full-text]
70. Array comparative genomic hybridization identifies genetic subgroups in grade 4 human astrocytoma.
    Clin Cancer Res, 11(8): 2907-18. [Abstract] [Full-text]
71. T11TS/S-LFA3 induces apoptosis of the brain tumor cells: a new approach to characterise the apoptosis associated genetic changes by arbitrarily primed-PCR.
    Cancer Lett, 222(1): 23-38. [Abstract] [Full-text]
72. Rac2 expression and mutation in human brain tumors.
    Acta Neurochir (Wien), 147(5): 551-4; discussion 554. [Abstract] [Full-text]
73. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Acta Neurochir (Wien), 147(5): 485-93; discussion 493. [Abstract] [Full-text]
74. Selection bias due to differential participation in a case-control study of mobile phone use and brain tumors.
    Ann Epidemiol, 15(5): 321-5. [Abstract] [Full-text]
75. Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme.
    Proc Natl Acad Sci U S A, 102(16): 5814-9. [Abstract] [Full-text]
76. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Acta Neuropathol (Berl), 109(3): 314-20. [Abstract] [Full-text]
77. Frequent gene amplification and overexpression of decoy receptor 3 in glioblastoma.
    Acta Neuropathol (Berl), 109(3): 294-8. [Abstract] [Full-text]
78. Fourth ventricle neurocytoma with lipomatous and ependymal differentiation.
    Acta Neuropathol (Berl), 109(3): 346-51. [Abstract] [Full-text]
79. Identification of differentially expressed genes in human pineal parenchymal tumors by microarray analysis.
    Acta Neuropathol (Berl), 109(3): 306-13. [Abstract] [Full-text]
80. Cerebral lipoma and the underlying cortex of the temporal lobe: pathological features associated with the malformation.
    Acta Neuropathol (Berl), 109(3): 339-45. [Abstract] [Full-text]
81. Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer.
    Cochrane Database Syst Rev. [Abstract] [Full-text]
82. Adjuvant chemotherapy in the treatment of high grade gliomas.
    Cancer Treat Rev, 31(2): 79-89. [Abstract] [Full-text]
83. Therapeutic management of brain metastasis.
    Lancet Neurol, 4(5): 289-98. [Abstract] [Full-text]
84. Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography.
    J Biomed Opt, 10(1): 11006. [Abstract] [Full-text]
85. Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study.
    Cancer, 103(9): 1874-80. [Abstract] [Full-text]
86. Congenital intracranial frontotemporal dermoid cyst presenting as a cutaneous fistula.
    Head Neck, 27(5): 429-32. [Abstract] [Full-text]
87. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Int J Radiat Oncol Biol Phys, 62(1): 20-31. [Abstract] [Full-text]
88. Intravascular lymphomatosis presenting with sudden hearing loss.
    J Neurol Sci, 232(1): 105-9. [Abstract] [Full-text]
89. Retrospective family study of childhood medulloblastoma.
    Am J Med Genet A, 134(4): 399-403. [Abstract] [Full-text]
90. Assimilating intraoperative data with brain shift modeling using the adjoint equations.
    Med Image Anal, 9(3): 281-93. [Abstract] [Full-text]
91. Experimental models of brainstem tumors: development of a neonatal rat model.
    Childs Nerv Syst, 21(5): 399-403. [Abstract] [Full-text]
92. Choroid plexus adenoma: case report and review of the literature.
    Childs Nerv Syst, 21(5): 410-5. [Abstract] [Full-text]
93. Post-shunt ascites in infants with optic chiasmal hypothalamic astrocytoma: role of ventricular gallbladder shunt.
    Childs Nerv Syst, 21(5): 382-4. [Abstract] [Full-text]
94. Proton magnetic resonance spectroscopic imaging in pediatric pilomyxoid astrocytoma.
    Childs Nerv Syst, 21(5): 404-9. [Abstract] [Full-text]
95. Expression and activity of l-isoaspartyl methyltransferase decrease in stage progression of human astrocytic tumors.
    Brain Res Mol Brain Res, 135(1): 93-103. [Abstract] [Full-text]
96. Multicentric glial brain tumors of a varying degree of differentiation in patient with chronic lymphocytic leukemia.
    Am J Hematol, 79(1): 50-3. [Abstract] [Full-text]
97. Loss of patched and disruption of granule cell development in a pre-neoplastic stage of medulloblastoma.
    Development, 132(10): 2425-39. [Abstract] [Full-text]
98. Increased fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) uptake in childhood CNS tumors is correlated with malignancy grade: a study with FDG positron emission tomography/magnetic resonance imaging coregistration and image fusion.
    J Clin Oncol, 23(13): 3030-7. [Abstract] [Full-text]
99. Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group.
    J Clin Oncol, 23(13): 2955-61. [Abstract] [Full-text]

© 2004-2012 Brain Cancer Research Today. All Rights Reserved.